![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and European League Against Rheumatism Annual European Congress of Rheumatology, 14–17 June, 2017 - ()] Poster Presentations - FRI0211 A descriptive analysis of real-world treatment patterns of innovator infliximab (REMICADE) and biosimilar infliximab in a treatment naÏve turkish rheumatologic disease population
Yazici, Y, Xie, L, Ogbomo, A, Parenti, D, Goyal, K, Teeple, A, Ellis, L, Simsek, ILanguage:
english
DOI:
10.1136/annrheumdis-2017-eular.1117
File:
PDF, 301 KB
english